DANA FABER CANCER INST INC has a total of 14 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COMPUGEN LTD, DYAX CORP and IMMUNOQURE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | Singapore | 2 | |
#5 | Colombia | 1 | |
#6 | Mexico | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Tedder Thomas F | 4 |
#2 | Kufe Donald W | 3 |
#3 | Zhou Liang-Ji | 2 |
#4 | Enerback Charlotta | 1 |
#5 | Bertino Joseph R | 1 |
#6 | Wagle Nikhil | 1 |
#7 | Marasco Wayne A | 1 |
#8 | Liddington Robert C | 1 |
#9 | Mitsiades Constantine S | 1 |
#10 | Freeman Gordon J | 1 |
Publication | Filing date | Title |
---|---|---|
US5710262A | Nucleic acid encoding HB15 polypeptides | |
US5316920A | Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |